Gary Jacob
Director Ejecutivo en OKYO PHARMA LIMITED .
Fortuna: 67 180 $ al 30/04/2024
Cargos activos de Gary Jacob
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Director/Miembro de la Junta | 23/12/2020 | - |
| Independent Dir/Board Member | 23/12/2020 | - | |
| OKYO PHARMA LIMITED | Director/Miembro de la Junta | 07/01/2021 | - |
| Director Ejecutivo | 07/01/2021 | - |
Historial de carrera de Gary Jacob
Antiguos cargos conocidos de Gary Jacob.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 15/05/2013 | 19/03/2014 |
| Director Ejecutivo | 15/05/2013 | 19/03/2014 | |
| Presidente | 19/03/2014 | 20/02/2024 | |
| Independent Dir/Board Member | 19/03/2014 | 20/02/2024 | |
| Presidente | 15/05/2013 | 19/03/2014 | |
| VIRPAX PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 28/04/2020 | 25/07/2022 |
| Independent Dir/Board Member | 28/04/2020 | 25/07/2022 | |
| IMMURON LIMITED | Director/Miembro de la Junta | 17/04/2019 | 25/03/2020 |
| Director Ejecutivo | 16/11/2018 | 25/03/2020 | |
| SYNERGY PHARMACEUTICALS INC | Director/Miembro de la Junta | 29/03/2011 | 05/05/2014 |
| Director Ejecutivo | 01/07/2008 | 19/12/2017 | |
| Presidente | 05/05/2014 | 01/01/2018 | |
| Fundador | - | 01/01/2018 | |
| Contacto de Relaciones con Inversores | 29/03/2011 | 06/05/2014 | |
| Public Communications Contact | 24/08/2011 | 06/05/2014 | |
| Presidente | 01/07/2008 | 19/12/2017 | |
| Synergy Pharmaceuticals, Inc. /Old/ | Director Ejecutivo | 01/07/2008 | 01/10/2017 |
| Presidente | 01/09/2013 | 01/10/2017 | |
| Fundador | 01/07/2008 | 01/10/2017 | |
| Presidente | 01/07/2008 | 01/10/2017 | |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director/Miembro de la Junta | 01/05/2003 | 22/01/2013 |
| Director Ejecutivo | 01/05/2003 | 22/01/2013 | |
| Director Técnico/Científico/I+D | 01/05/2003 | 22/01/2013 | |
| Public Communications Contact | 01/05/2003 | 22/01/2013 | |
| Presidente | 01/01/2004 | 22/01/2013 | |
| Pawfect Foods, Inc. | Director/Miembro de la Junta | 11/08/2008 | 11/08/2008 |
| Presidente | - | 11/08/2008 | |
| ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Gary Jacob.
| University of Wisconsin | Doctorate Degree |
| University of Missouri-St. Louis | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 14 |
| Reino Unido | 3 |
| Australia | 2 |
Operativa
| Director/Board Member | 9 |
| Chief Executive Officer | 6 |
| President | 5 |
Sectorial
| Health Technology | 10 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| IMMURON LIMITED | Health Technology |
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| Empresas privadas | 7 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Synergy Pharmaceuticals, Inc. /Old/ | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
| Synergy DE | |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| G.D. Searle LLC |
- Bolsa de valores
- Insiders
- Gary Jacob
- Experiencia
